Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Curis Inc (CRIS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Curis Inc 4 MAGUIRE ROAD LEXINGTON MA 02421 USA

P: 617-503-6500 F: 617-503-6501

Description:

Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease.

Key Statistics

Overview:

Market Capitalization, $K 37,414
Shares Outstanding, K 33,113
Annual Sales, $ 9,900 K
Annual Net Income, $ -53,320 K
Last Quarter Sales, $ 2,850 K
Last Quarter Net Income, $ -7,220 K
36-Month Beta 2.05
% of Insider Shareholders 4.34%
% of Institutional Shareholders 30.47%

Growth:

1-Year Total Return -57.36%
3-Year Total Return -84.83%
5-Year Total Return -92.59%
5-Year Revenue Growth -41.66%
5-Year Earnings Growth -176.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/14/19
Earnings Per Share ttm -1.08
EPS Growth vs. Prev Qtr 15.38%
EPS Growth vs. Prev Year 60.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-5 on 05/30/18

CRIS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.61
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -299.20
Return-on-Assets (Before Tax) -59.60
Net Margin % -486.84
Debt/Equity 38.74
Price/Sales 3.42
Price/Cash Flow N/A
Price/Book 47.55
Book Value/Share -0.02
Interest Coverage -12.43
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar